This site is intended for UK healthcare professionals
Medscape UK Univadis Logo
Medscape UK Univadis Logo

Welcome to the new home of Guidelines in Practice

For Primary Care | Top tips

Top Tips: Pertussis

Dr Toni Hazell Offers Five Top Tips for Primary Care Covering the Latest Guidance on When to Suspect Pertussis, How to Manage It, and Public Health Aspects of the Condition

Read This Article to Learn More About:
  • the importance of vaccinating against pertussis, particularly in pregnancy, and addressing vaccine hesitancy and safety concerns 
  • the clinical presentation of pertussis, and its impact on the health of newborns
  • how to recognise, treat, refer, and report a suspected case of pertussis, and when to treat close contacts.
Key points can be found at the end of this article.

Reflect on your learning and download our Reflection Record.
Read the related Guidelines summary, Pertussis: Guidelines for Public Health Management, by clicking here.

Pertussis, colloquially known as whooping cough, is caused by the bacterium Bordetella pertussis.1 Similarly to measles, pertussis was endemic in the UK before vaccination, with over 120,000 cases per year in England and Wales.1 This number plummeted when immunisation was introduced in the 1950s, but a subsequent lack of confidence in the vaccine led to outbreaks in the late 1970s and early 1980s.1 

Unfortunately, the UK is again in a position where many people are turning down the potentially life-saving intervention of vaccination, and preventable diseases are becoming more prevalent. In the whole of 2023, there were 858 laboratory-confirmed cases of pertussis; this has already been overtaken by the 4793 cumulative total cases in England between January and April 2024.2 If diagnoses continue to rise at this rate, cases in 2024 may be ten times those in 2023.

This article provides five top tips for primary care on uptake of pertussis vaccination and its importance in pregnant women, the clinical presentation and treatment of pertussis, and how and when to report and refer cases of pertussis.

1. Understand the Importance of Pertussis Vaccination

Vaccination against pertussis is given at 8, 12, and 16 weeks of age, with a preschool booster at 3 years and 4 months.3 Vaccine uptake in the UK has been at least 92% since 1992; however, in 2011/12, despite maintenance of vaccine uptake, there was an outbreak of pertussis in England and Wales among infants, adolescents, and adults.1 This was partly attributed to the fact that protection after vaccination decreases over time, affecting herd immunity.1,4 This is a particular concern for newborns, who are too young to be vaccinated, and rely upon the transfer of maternal antibodies across the placenta for protection in the first weeks of life.5 In 2012, this was addressed with the introduction of a pertussis vaccination given from 16 weeks of pregnancy.5 This is a hugely effective intervention, offering around 90% effectiveness against confirmed pertussis in an infant, and 97% effectiveness against death from pertussis under the age of 3 months.6

It is therefore disappointing that uptake is less than ideal, running at around two-thirds in 2022/23.7 Uptake is lowest in London, with the next lowest area being the North West of England.7,8 GPs who are approached by patients with concerns about vaccination during pregnancy may wish to point them to the public-facing page about this subject on the website of the Oxford Vaccine Group.9

2. Address Vaccine Hesitancy and Safety Concerns

Whereas it is fear of autism that prevents parents from giving their children the measles, mumps, and rubella vaccine,10 concerns about the pertussis vaccine arose following a claim that it could cause brain damage in young children.11 These concerns started in the 1970s, and caused vaccination rates to drop from 78.5% in 1971 to 37% in 1974 (England and Wales), with the predictable consequence of a serious pertussis outbreak in 1978/79.11 Parents whose children have or are suspected of having a neurological condition may therefore be nervous about vaccinating, but the Green book offers reassurance, reviewing the evidence in this area and concluding that many cases of encephalopathy that were attributed to the pertussis vaccine turned out to be children with undiagnosed Dravet syndrome—a rare genetic condition that presents with seizures, encephalopathy, and developmental delay.1,12 

It is those who are hesitant about vaccination, rather than full-on vaccine deniers, who present the best opportunity to change opinion.13 People who point to the waning of vaccine protection as a reason not to bother with vaccination can be reassured that pertussis in a previously vaccinated person is less severe.14 

Adverse Reactions and Contraindications to the Pertussis Vaccine

Although it is possible (but rare) to develop an acute neurological illness as a reaction to the whole-cell pertussis vaccine, most children in whom this has occurred experienced no long-term harm.1 In any case, the whole-cell vaccine is not used in the UK, where the safer acellular vaccine is given instead.15 The risk of febrile seizures from the acellular vaccine is less than 1 in 10,000, and febrile seizures generally have no long-term consequences.15 Around three or four children in 10,000 will have a hypotonic hyporesponsive episode after vaccination, when the child becomes pale and limp for a short period but quickly recovers.15,16 Although this is extremely frightening for parents, there are no long-term consequences, and this does not generally recur with subsequent doses, so the course of vaccination can be completed.15,16 It is not possible to catch pertussis from the vaccine; however, it is possible to develop neurological complications from catching pertussis, which include seizures and cerebral hypoxia.1,17

GPs are sometimes asked whether a particular child who has been brought for vaccination can safely have it that day. There are very few absolute contraindications, apart from obvious ones such as confirmed anaphylaxis to a previous dose or to certain drugs that may be present in trace amounts in the vaccine (neomycin, streptomycin, and polymyxin B).1 Children with a stable neurological condition can be safely vaccinated, although it is recommended to wait if the child has evolving neurological abnormalities, current neurological deterioration, or poorly controlled epilepsy.1 In these situations, it would be wise to seek advice from the child’s consultant.1 Similarly, children who have had febrile seizures in the past with no neurological deterioration, or who have a family history of seizures, can be safely vaccinated.1

3. Recognise the Complex Clinical Presentation of Pertussis

As well as encouraging vaccination, the GP has a role to play in looking out for cases of pertussis, treating them appropriately, and notifying public health authorities. Unfortunately, as with many other highly infectious illnesses, pertussis is infectious long before GPs are likely to suspect anything other than a common cold.17,18 Between 1 and 3 weeks after exposure, the child will enter the catarrhal phase and develop a runny nose, sore throat, cough, and malaise, usually with a normal temperature or mild fever.17,18 They will then progress into the paroxysmal phase, which can last up to 10 weeks; the length of these two phases combined has given pertussis the nickname of ‘the 100-day cough’.17,19,20

Diagnosing pertussis is always going to be a challenge. In an average winter, GPs will see hundreds of children with cough or coryza. The key to suspecting pertussis is in the nature of the cough—it is violent, with uncontrolled coughing fits.17,18 The name ‘whooping cough’ comes from the ‘whoop’ sound, which is made by a short expiration followed by an inspiratory gasp (this video provides a useful example of the ‘whoop’ sound associated with pertussis).17,18,21 It is most commonly seen in children, and is less common in adults and babies aged under 3 months.18 Coughing fits occur regularly (an average of 15 in 24 hours), and can cause vomiting, cyanosis in children, and sweating or cough syncope in adults.21 Again, fever is either not present or very mild.21 After a paroxysmal phase of up to 10 weeks, there is a convalescent phase of 2–3 weeks in which the cough improves, but a paroxysmal cough may recur if another respiratory tract infection is caught.20,21 

Information on what to look out for in suspected cases of pertussis is presented in Box 1.6

Box 1: Case Definitions for Pertussis6

Suspected case of pertussis:

Any person in whom a clinician suspects pertussis infection. This may include individuals presenting with a new-onset cough without a clear alternative cause and one or more of the following features:

  • paroxysms of coughing
  • post-tussive vomiting
  • inspiratory whoop
  • cough of duration 14 days or more

(in the absence of laboratory confirmation or epidemiological link to a laboratory confirmed case).

Epidemiologically linked case of pertussis:

Any person with signs and symptoms consistent with pertussis and:

  • was in close contact with a laboratory-confirmed case of pertussis in the 21 days before onset of their cough

(in the absence of laboratory confirmation).

© UK Health Security Agency. Guidance on the management of cases of pertussis in England during the re-emergence of pertussis in 2024. London: UKHSA, 2024. Available at: assets.publishing.service.gov.uk/media/65f03577981227001af612b7/UKHSA_Guidance_on_
the_management_of_cases_of_Pertussis_during_high_activity_2024.pdf

Contains public sector information licensed under the Open Government Licence v3.0.

4. Know How to Report and Treat Suspected Pertussis

Pertussis is a notifiable disease; notification (which is a statutory duty for registered medical professionals22) is done at the point of suspicion of the infection by contacting the local authority or UK Health Security Agency health protection team.23 It is useful for GPs to have the notification form24 uploaded to their clinical system with demographic information already filled in. This should be sent to the local public health team, contact details for which can be found online for England, Scotland, Wales, and Northern Ireland.22 Usually, the public health team will then contact the patient directly and arrange for diagnostic testing. 

The method of diagnosis varies depending on the time since last pertussis vaccination and the duration of the cough. It may include culture or polymerase chain reaction analysis of a nasopharyngeal aspirate sample or swab, serology, or oral fluid testing.6 The patient should stay away from work or school for 2 days after they have started antibiotics, or for 21 days after the onset of symptoms if antibiotics are not given.18,23 

Antibiotic Prescription

Although good antibiotic stewardship is essential, if pertussis is suspected and it is within 14 days of the onset of the cough, then antibiotics are indicated.6 Specifically, patients should be prescribed a macrolide;19 this may or may not significantly shorten the duration of the cough,18 and it can take several weeks to resolve completely. Antibiotics do not have any benefit (in terms of reducing either symptoms or infectivity) if given more than 21 days after the onset of the cough.18

When to Treat Close Contacts 

A close contact is defined as a family member, someone living in the same household, or those in institutions such as boarding schools who sleep in the same room.6 Work contacts and those in the same class at school are generally not defined as close contacts.6 Close contacts should also be treated if the index case has had symptoms for less than 21 days and the close contact is in a priority group for public health action.6 These largely consist of babies, pregnant women, and those in close contact with babies; more detail is given in Box 2.6,19

Box 2: High Priority Groups for Public Health Action6 

Group 1: Individuals at increased risk of severe complications (‘vulnerable’)

  • Unimmunised infants (born from 32 weeks) under 2 months of age regardless of maternal vaccine status, or
  • Unimmunised infants (born from 32 weeks) under 2 months of age whose mothers did not receive maternal pertussis vaccine after 16 weeks and at least 2 weeks before delivery, or
  • Infants from 2 months to less than 5 months of age, regardless of maternal vaccination status or gestational age at delivery, or
  • Infants from 5 months to less than 1 year of age who have received less than three doses of a pertussis-containing vaccination (for example, DTaP/IPV/Hib/HepB), regardless of maternal vaccination status or gestational age at delivery.

Groups 2: Individuals at increased risk of transmitting to ‘vulnerable’ individuals in ‘Group 1’ if they have pertussis, who have not received a pertussis-containing vaccine more than 1 week and less than 5 years ago

  • Pregnant women who have reached 32 weeks’ gestation
  • HCWs who provide close personal care to infants (as defined in Group 1 above) and pregnant women
  • People whose work involves regular, close, and prolonged contact with infants as defined in Group 1 above (for example, nursery workers in baby rooms)
  • People who share a household with an infant as defined in ‘vulnerable’ infants in Group 1 above.

DTaP/IPV/Hib/HepB=diphtheria, tetanus, pertussis, polio, Haemophilus influenzae type b, and hepatitis B; HCW=healthcare worker

© UK Health Security Agency. Guidance on the management of cases of pertussis in England during the re-emergence of pertussis in 2024. London: UKHSA, 2024. Available at: assets.publishing.service.gov.uk/media/65f03577981227001af612b7/UKHSA_Guidance_
on_the_management_of_cases_of_Pertussis_during_high_activity_2024.pdf

Contains public sector information licensed under the Open Government Licence v3.0.

Contacts do not need to stay off work or school, but should be offered immunisation if they are not already fully immunised.19 A booster should also be offered to any contact aged 10 years or older who has not had a vaccination in the preceding 5 years and has not had a tetanus/diphtheria/polio vaccine in the preceding month.19 If in doubt, the local health protection team should be able to advise on this; strictly speaking, treatment of contacts is not contractually the responsibility of general practice, and should be undertaken by public health authorities, unless there is an enhanced service in the locality that enables this.6 The index case should also receive any outstanding immunisations after they have recovered from the acute illness.19

5. Refer to Secondary Care When Appropriate

In England, between 2013 and the end of April 2024, there have been 29 deaths of babies too young to be fully vaccinated—this includes eight deaths in infants between January and April 2024.2 As always, anyone who appears to be severely unwell (for example, significant dyspnoea or apnoeic events) should be referred to hospital, but GPs should also refer all those aged 6 months or younger with suspected pertussis,19 and tell their parents or carers that they are likely to be admitted. This is because most complications and deaths occur in this age group, and the mortality rate for pertussis is 1% in those aged under 2 months.25 

Summary 

Whooping cough is a very unpleasant infection; it can cause a cough that persists for many weeks, and is associated with significant mortality in infants. Cases are rising, so it is a diagnosis that should be on the radar—GPs must be prepared to treat and notify at the point of suspicion, and should actively promote pertussis vaccination to pregnant women and anyone else who is not fully vaccinated.

Key Points
  • Pertussis, also known as whooping cough, is on the rise, with 4793 cumulative cases between January and April 2024
  • Vaccine uptake has decreased and protection from vaccination wanes with time—this puts newborns at risk if they are not protected by transplacental maternal antibodies
  • All pregnant women should therefore be vaccinated during pregnancy
  • The only absolute contraindications to vaccination are anaphylaxis to the vaccine or its constituents
  • Previous concerns about neurological adverse effects are unproven—deferring is only recommended if there are evolving neurological abnormalities or poorly controlled epilepsy
  • Pertussis presents much like other respiratory tract infections—if the persistent and distinctive cough is recognised within 14 days, antibiotics should be given
  • Pertussis is notifiable at the point of suspicion
  • Any child aged under 6 months with suspected pertussis should be referred to Paediatrics.
Implementation Actions for ICSs

written by Dr David Jenner, GP, Cullompton, Devon

The following implementation actions are designed to support ICSs with the challenges involved in implementing new guidance at a system level. Our aim is to help you to consider how to deliver improvements to healthcare within the available resources.

  • Liaise with local health protection teams to determine how best to respond to the latest pertussis outbreak
  • Identify any areas and/or population groups with low vaccine uptake and target vaccine promotion messaging to them
  • Encourage pertussis vaccination in all pregnant women, as this is an effective way of preventing neonatal pertussis
  • Provide and publish leaflets and/or web-based material explaining the safety and effectiveness of pertussis vaccination, so that healthcare teams can use them to promote vaccination
  • Share guidance on diagnosing, treating, and reporting suspected pertussis infection with all first-contact healthcare services, including appropriate advice on antibiotics.

ICS=integrated care system


References


YOU MAY ALSO LIKE

Streeting has faced criticism from within his own party for the decision.
Tisotumab vedotin reduced the risk of dying by 30% in this phase 3 trial.
Hospitalisations and deaths did not decline over the course of a decade.
In the first of a series on the impact of sex-specific factors on CVD, Dr Shrilla Banerjee and Dr F Aaysha Cader outline how differences in risk between men and women should be reflected in guidance
Opioid overdose rates rose in seniors; less than half received necessary treatment. Clinicians can focus on safer pain management and reducing addiction risks via screening and patient-centered care.
Severe shortness of breath and night sweats in a 48-year-old man was diagnosed as ‘crack lung’ due to cocaine use.
Incisions have become smaller and less invasive over time, according to one gynecologist.
An AI-enabled system of wearable coils and ingestible "smart" pills shows promise for identifying and tracking gasses in the GI tract associated with digestive disorders.
Valerie Benfield, Head of Events, answers the Guidelines in Practice Team's questions about the Management Stream at Guidelines Live—a brand new stream for the 2024 event
Experts are optimistic that image analysis, natural language processing, and generative AI will soon become foundational to the management of patients with IBD.
There's a range of options available for healthcare professionals to offer people when a flutter during a summer of sport turns into more serious gambling problems.
Boosting levels with diet and supplements reduced numbers of skin lesions and improved quality of life.
Depressed parent symptoms track together and ultimately lead to depression in teenage offspring.
Around 9000 patients in England currently receiving ocrelizumab infusions will switch to the new 10-minute injection, thanks to the NHS rollout.
A proposed major shift from a clinical definition of Parkinson's disease to the one based on biology has triggered debate among experts in the field.
Faltering economic growth means the UK has less money to spend on health than some of its European neighbours. Can it catch up?
Digital technologies are being developed to objectively measure indicators of a disease and treatment response. But will they reach clinical practice?
In an alarming case, a Brazilian doctor received 1300 messages from a stalker in a single day.
Positive results from the DanGer Shock trial were expected to alter the course of competing studies of the world's smallest heart pump, and for RECOVER IV, the trial is terminated.
Many doctors and their organizations spoke out against the far right during the recent elections, but their political clout may be less than is imagined.